Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
103.18 USD | -0.18% | +4.29% | -15.56% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.04TCr | 1.95TCr | 2.2TCr | 1.97TCr | 1.95TCr | |||||
Total Revenues | 2.04TCr | 1.95TCr | 2.2TCr | 1.97TCr | 1.95TCr | |||||
Cost of Goods Sold, Total | 1.69TCr | 1.56TCr | 1.76TCr | 1.67TCr | 1.63TCr | |||||
Gross Profit | 353.3Cr | 385Cr | 440.9Cr | 307.3Cr | 317Cr | |||||
Selling General & Admin Expenses, Total | 214.7Cr | 189.4Cr | 203.4Cr | 172.5Cr | 198Cr | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 6.9Cr | 6.2Cr | 4.7Cr | 3.5Cr | 4Cr | |||||
Other Operating Expenses, Total | 221.6Cr | 195.6Cr | 208.1Cr | 176Cr | 202Cr | |||||
Operating Income | 131.7Cr | 189.4Cr | 232.8Cr | 131.3Cr | 115Cr | |||||
Interest Expense, Total | -19Cr | -19Cr | -18Cr | -19Cr | -35Cr | |||||
Interest And Investment Income | - | 18Cr | - | - | 1.8Cr | |||||
Net Interest Expenses | -19Cr | -70L | -18Cr | -19Cr | -33Cr | |||||
Income (Loss) On Equity Invest. | - | - | -80L | -1.9Cr | -2.8Cr | |||||
Currency Exchange Gains (Loss) | 13Cr | -14Cr | 26Cr | 5.6Cr | -80L | |||||
Other Non Operating Income (Expenses) | 10Cr | - | -19Cr | -8.8Cr | - | |||||
EBT, Excl. Unusual Items | 136.2Cr | 174.3Cr | 221.5Cr | 107.2Cr | 78Cr | |||||
Restructuring Charges | -19Cr | -29Cr | -3.8Cr | -2.1Cr | -1.6Cr | |||||
Merger & Related Restructuring Charges | - | - | - | -4.4Cr | - | |||||
Impairment of Goodwill | - | - | - | -28Cr | - | |||||
Gain (Loss) On Sale Of Investments | - | - | 4.2Cr | - | - | |||||
Gain (Loss) On Sale Of Assets | 44Cr | 70L | 10Cr | -186.9Cr | -11Cr | |||||
Asset Writedown | - | -70L | - | -11Cr | - | |||||
Legal Settlements | - | - | - | - | -9.4Cr | |||||
Other Unusual Items | -5.9Cr | - | - | - | - | |||||
EBT, Incl. Unusual Items | 155.2Cr | 145.5Cr | 232.4Cr | -124.6Cr | 56Cr | |||||
Income Tax Expense | 35Cr | 38Cr | 52Cr | 26Cr | 7.7Cr | |||||
Earnings From Continuing Operations | 119.8Cr | 107.1Cr | 180.6Cr | -151.1Cr | 49Cr | |||||
Net Income to Company | 119.8Cr | 107.1Cr | 180.6Cr | -151.1Cr | 49Cr | |||||
Minority Interest | -1.4Cr | 1Cr | -2.3Cr | -80L | -70L | |||||
Net Income - (IS) | 118.4Cr | 108.1Cr | 178.3Cr | -151.9Cr | 48Cr | |||||
Net Income to Common Incl Extra Items | 118.4Cr | 108.1Cr | 178.3Cr | -151.9Cr | 48Cr | |||||
Net Income to Common Excl. Extra Items | 118.4Cr | 108.1Cr | 178.3Cr | -151.9Cr | 48Cr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 18.59 | 17.24 | 28.71 | -27.17 | 8.75 | |||||
Basic EPS - Continuing Operations | 18.59 | 17.24 | 28.71 | -27.17 | 8.75 | |||||
Basic Weighted Average Shares Outstanding | 6.37Cr | 6.27Cr | 6.21Cr | 5.59Cr | 5.5Cr | |||||
Net EPS - Diluted | 18.45 | 17.07 | 28.36 | -27.18 | 8.72 | |||||
Diluted EPS - Continuing Operations | 18.45 | 17.07 | 28.36 | -27.18 | 8.72 | |||||
Diluted Weighted Average Shares Outstanding | 6.42Cr | 6.33Cr | 6.29Cr | 5.59Cr | 5.52Cr | |||||
Normalized Basic EPS | 13.14 | 17.53 | 21.92 | 11.84 | 8.75 | |||||
Normalized Diluted EPS | 13.04 | 17.36 | 21.64 | 11.84 | 8.72 | |||||
Dividend Per Share | 4.75 | 4.85 | 5.45 | 7 | 7 | |||||
Payout Ratio | 25.76 | 28.77 | 18.96 | -25.67 | 79.83 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 190.4Cr | 246.2Cr | 282.2Cr | 178.8Cr | 147.7Cr | |||||
EBITA | 138.6Cr | 195.6Cr | 237.5Cr | 134.8Cr | 119Cr | |||||
EBIT | 131.7Cr | 189.4Cr | 232.8Cr | 131.3Cr | 115Cr | |||||
EBITDAR | 211.8Cr | 269.8Cr | 305.6Cr | 200.6Cr | 171.2Cr | |||||
Effective Tax Rate - (Ratio) | 22.81 | 26.39 | 22.29 | -21.27 | 13.63 | |||||
Current Domestic Taxes | 24Cr | 13Cr | 21Cr | -4.9Cr | -3Cr | |||||
Current Foreign Taxes | 43Cr | 18Cr | 18Cr | 18Cr | 20Cr | |||||
Total Current Taxes | 68Cr | 31Cr | 40Cr | 13Cr | 17Cr | |||||
Deferred Domestic Taxes | 8.3Cr | 9.4Cr | 25Cr | 4.9Cr | -24Cr | |||||
Deferred Foreign Taxes | -41Cr | -2.4Cr | -13Cr | 8.5Cr | 16Cr | |||||
Total Deferred Taxes | -32Cr | 7Cr | 12Cr | 13Cr | -9Cr | |||||
Normalized Net Income | 84Cr | 109.94Cr | 136.14Cr | 66Cr | 48Cr | |||||
Non-Cash Pension Expense | 40L | 4Cr | -60L | -1Cr | 2.2Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 34Cr | 27Cr | 34Cr | 33Cr | 39Cr | |||||
Research And Development Expense From Footnotes | 54Cr | 46Cr | 48Cr | 46Cr | 47Cr | |||||
Net Rental Expense, Total | 21Cr | 24Cr | 23Cr | 22Cr | 24Cr | |||||
Imputed Operating Lease Interest Expense | 5.35Cr | 5.87Cr | 5.28Cr | 4.6Cr | 8.15Cr | |||||
Imputed Operating Lease Depreciation | 16Cr | 18Cr | 18Cr | 17Cr | 15Cr | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | 6.7Cr | 8.2Cr | 5.8Cr | 3.3Cr | |||||
Stock-Based Comp., Other (Total) | 5Cr | - | - | - | - | |||||
Total Stock-Based Compensation | 5Cr | 6.7Cr | 8.2Cr | 5.8Cr | 3.3Cr |